Strides Pharma Science Limited
STAR.BO·BSE·Healthcare
1,006.00−5.90 (−0.58%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1,011.90
Open1,039.80
Day range995.401,039.80
52-week range769.601,260.10
Off day high−3.25%
Off 52-week high−20.17%
Volume12.87K
Avg. volume (3M)24.27K
Market cap92.73B
EPS (TTM)66.91
Forward P/E11.70
P/E ratio (TTM)15.04
Dividend yield0.49% (5.00)
Beta (5Y)0.36
Shares outstanding92.17M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target1,304.67
Profit margin11.83%
Against its peers
Compare in full ›| STAR.BO | TAK | 1795.TW | SHILPAMED.NS | NATCOPHARM.NS | MEGA.BK | |
|---|---|---|---|---|---|---|
| Market cap | 92.73B | 67.28B | 44.76B | 180.29B | 156.27B | 30.95B |
| P/E (TTM) | 15.0 | 300.9 | 11.8 | 65.1 | 12.6 | 14.2 |
| Forward P/E | 11.7 | 39.7 | 7.1 | 44.2 | 16.8 | 12.4 |
| Price/book | 2.7 | 1.4 | 1.9 | 7.0 | 1.5 | 3.0 |
| Dividend yield | 0.49% | 2.93% | 1.61% | 0.06% | 0.75% | 4.86% |
| 1-year change | +8.29% | +54.40% | −42.88% | +152.54% | −4.67% | +20.69% |
| Today | −0.58% | +1.49% | +5.66% | −1.00% | +1.00% | +1.43% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All STAR.BO news ›Strides Pharma Science Q2 profit up 2 pc at Rs 134 cr
New Delhi, Oct 29 (PTI) Strides Pharma Science Ltd on Thursday reported a 2 per cent rise in its profit after tax (PAT) for the second quarter ended September to Rs 134.1 crore, driven by revenue growth. The pharma company had posted a net…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Themes
Most coverage from
- news18.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.